PharmaNutra SpA (FRA:761) Other Net Income (Loss) : €-0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PharmaNutra SpA Other Net Income (Loss)?

PharmaNutra SpA's Other Net Income (Loss) for the three months ended in Sep. 2024 was €0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.0 Mil.

PharmaNutra SpA's quarterly Other Net Income (Loss) declined from Mar. 2024 (€-0.0 Mil) to Jun. 2024 (€-0.0 Mil) but then increased from Jun. 2024 (€-0.0 Mil) to Sep. 2024 (€0.0 Mil).

PharmaNutra SpA Other Net Income (Loss) Historical Data

The historical data trend for PharmaNutra SpA's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaNutra SpA Other Net Income (Loss) Chart

PharmaNutra SpA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

PharmaNutra SpA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

PharmaNutra SpA Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.0 Mil.

PharmaNutra SpA Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of PharmaNutra SpA's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaNutra SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaNutra SpA (FRA:761) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

PHN:Italy

Address

Via Campodavela 1, Pisa, ITA, 56122

Website

https://www.pharmanutra.it

PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, Asia, and others.

PharmaNutra SpA Headlines

No Headlines